COVID-19 Therapeutic Alert

The UK-wide clinical commissioning policy has now been revised to reflect the availability of the nMAB sotrovimab (from the week commencing 20 December) and the current understanding of the likely imp
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news